🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out the latest developments of all things PGS Catalog, out now in Nature Genetics (🔗: rdcu.be/dVakA )! In this paper we describe big increases in the data content (and diversity) and our tool for PGS calculation (github.com/PGScatalog/pgs…).

⁦I hope you’ll be joining us at the 20th Congress of the ⁦Immunology of Diabetes Society⁩ November 4-8 in Bruges. Don’t forget to make arrangements to vote early or by mail before your travels! Civic duty ✅. #itsanimportantone 😱 ⁦VoteGov⁩

📧 Planning to attend IDS Bruges as US citizen? Make sure that your vote is counted for the upcoming #Election2024 through early voting or absentee voting💪

#AcademicChatter #AcademicX

The Generation Study is a ground-breaking research study in partnership with the NHS which will sequence the whole genomes of up to 100,000 newborn babies and look for 200+ rare conditions in early childhood. Find out more: ow.ly/RVuJ50TBVQf Department of Health and Social Care NHS England

>5000 Polygenic scores now available at PGSCatalog.org! As of today's release we've broken 5k PGS, indexing data from 673 unique publications. A big thank you to the authors submitting their data and our team in pursuit of #openscience, #FAIRdata, and reproducibility!

Richard Oram JC Katte Why should we screen people for #Type1Diabetes? 🤔 CEO of Breakthrough T1D UK, Karen Addington, has written a fantastic blog post on the subject 👇 breakthrought1d.org.uk/resources/earl…

You don’t need luck - you’ll be amazing !! Enjoy the meeting JC Katte NIHR Exeter Biomedical Research Centre (BRC)

Delighted to have presented for the first time a more extended version of the work I am leading at #ISPAD50 with a host of colleagues from #Africa and #UK NIHR Exeter Biomedical Research Centre (BRC). Pediatric #diabetes in Africa is mostly not T1D, T2D or monogenic diabetes. It’s something else 🧐

Join Dr. Teresa Mastracci , Claus Jorgensen 🇪🇺🇩🇰 , Maureen Gannon, and me at the Gordon Research Conference (GRC) on Pancreatic Diseases in June - "where the endocrine and exocrine pancreas meet". Registration is now open grc.org/pancreatic-dis…

Dr Ronald Ma Richard Oram @mnweedon CUHK Medicine Beta-cell-dysfunction and lipodystrophy could be the driving pathological pathways in T2D individuals with normal weight. Genetic risks of beta-cell-dysfunction and obesity are two major genetic drivers of T2D heterogeneity in disease progression and diabetic complications (P2).

Really excited to share this super translational project from rockstar Chaitra Rao ! Islets and T cells and EVs- what more could you want ❤️?

An honour to speak to Grant King about his experiences of HNF1B MODY and the great support network he set up for patients. Coralie Bingham established this as the commonest cause of inherited kidney disease @athattersley Exeter Med School 1in6b.com/series-3-episo…

Want to generate #T1DGRS in your data or data from any biobank? Seth Sharp has updated his #GRS2 originally developed with Richard Oram & @mnweedon - code available on GitHub Great collaboration with Amber Luckett medrxiv.org/content/10.110… github.com/sethsh7/prsedm Stanford Pediatrics

5-drug precision prescribing for people with type 2 diabetes is here - The Lancet our @ExeterMedmodel for optimising glucose lowering therapy using low-cost routine clinical features Paper: thelancet.com/journals/lance… Web calc: diabetesgenes.org/t2-treatment/

In 35 years of diabetes research This work from John Dennis is the most important I have been involved with in 25 years in research! Doctors can know, for first time, the likely glucose lowering of 5 drugs for specific patients. Uses routine data so no cost. Try it see below!

In case it helps save someone from wasting a couple hours of their life, #EndNote seems to not be handshaking with #PubMed. Tried switching computers, rebooting, updating EndNote, and typing various combinations. Fortunately Clarivate Web of Science selection under 'Online

Pleased to share our new preprint medrxiv.org/content/10.110… - Genetically confirmed MODY have high T2D risk ~ 24% of phenotypic variance due to common genetic changes - polygenic background alters diabetes risk 18 to 81%

We have the chance to eradicate life threatening #DKA at T1D Diagnosis which 26% of children in the UK experience. An NHS screening programme could save lives, prevent DKA & reduce long term #T1D complications. Thank you Sarah Bool for raising #T1D #EarlyDetection at PMQs today

Delighted to be able to contribute to this effort together with Richard Oram University of Exeter Zhiguang Zhou and Yang Xiao from the National Clincial Research Centre for Metabolic Diseases, 2nd Xiangya Hospital of Central South University. The T1D C-GRS helps diagnosis #precisionmedicine